DM-BOOST Para Latinx: a Diabetes Mellitus Program Using Behavioral Economics to Optimize Outreach and Self-management Support with Technology for Latinx Patients

Not Applicable

Recruiting

• Conditions: Diabetes Mellitus, Type 2

• Registration Number: NCT05583877
• Lead Sponsor: Daniel Amante

Brief Summary

The specific aims of this project are to culturally adapt the DM-BOOST intervention for Latinx patients, usability test 'DM-BOOST para Latinx' to optimize cultural appropriateness and patient engagement and conduct a feasibility evaluation of DM-BOOST para Latinx. These aims will be accomplished via a community-based participatory research approach in collaboration with clinical, community and patient partners. This project will inform subsequent proposals to evaluate implementation of DM-BOOST in the UMass Memorial Health Care system.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2022-10-13
• Study First Submitted QC: 2022-10-13
• Study First Posted: 2022-10-18
• Study Start: 2024-12-01
• Status Verified: 2025-03
• Last Update Submitted: 2025-03-10
• Last Update Posted: 2025-03-11
• Primary Completion: 2025-05-01
• Study Completion: 2025-05-01

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 70

Inclusion Criteria

• Age > 18 years
• Diagnosis of type 2 diabetes
• Identifies as Hispanic/Latinx
• Spanish language preference

Aims 1 and 2 Patient

Exclusion Criteria

• Cognitive impairment
• Current prisoner
• Pregnant women

Aim 3 Patient Inclusion Criteria:

• Age > 18 years
• Diagnosis of type 2 diabetes
• Identifies as Hispanic/Latinx
• Spanish language preference

Aim 3 Patient Exclusion Criteria:

• Cognitive impairment
• Current prisoner
• Pregnant women
• Completed DSMT in previous year

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
Process Evaluation	3 - 6 months	Evaluate engagement by examining the number of DSMT appointments scheduled, cancellation/no show rates and total number of DSMT-related encounters completed.

Secondary Outcome Measures

Name	Time	Method
Diabetes self-efficacy	3 months	Diabetes self efficacy will be measured at baseline and 3 months after enrolling in the study using the Diabetes Management Self-Efficacy Scale. Participants will provide feedback on set of questions, using a 5-point Likert scale( with 1=Strong Disagree, 2=Somewhat Disagree, 3= Neutral, 4=Somewhat Agree, 5= Strongly Agree)
Diabetes treatment satisfaction	3 months	Diabetes Treatment Satisfaction will be measured at 3 months after enrolling in the study using the Diabetes Treatment Satisfaction Questionnaire Change tool. Participants will be asked to share how their experience of current treatment has changed from their experience of treatment before the study began. They will answer each question by choosing 3 for Much More Satisfied Now up to -3 for Much Less Satisfied Now. (3,2,1,0,-1,-2,-3)
Change in HbA1c Percentage	6 months	Measurement of HbA1c values to determine impact of intervention. HbA1c values at baseline visit will be compared with values at 3-6 months after participant's enrollment. These data will be obtained through EHR chart review.

Trial Locations

Locations (2)

UMass Memorial health; 🇺🇸 Worcester, Massachusetts, United States

University of Massachusetts Medical School; 🇺🇸 Worcester, Massachusetts, United States